Clinical Practice Guidelines – Constipation in advanced cancer

Diagnosis, Assessment and Management of Constipation in Advanced Cancer: ESMO Clinical Practice Guidelines

Published in 2018 - Ann Oncol (2018) 29 (Suppl 4): iv111–iv125
Authors: P. J. Larkin, N. I. Cherny, D. La Carpia, M. Guglielmo, C. Ostgathe, F. Scotte & C. I. Ripamonti, on behalf of the ESMO Guidelines Committee

Constipation is a common subjectively experienced problem and a significant source of major morbidity and distress. The 2018 ESMO Clinical guidelines on Diagnosis, assessment and management of constipation in advanced cancer update evidence in relation to strategies for management. Opioid analgesics for cancer pain pose specific challenges for constipation management. A recommendation for the use of peripherally-acting mu-opioid receptor antagonists (PAMORAS) including prolonged-released formulations in the management of refractory constipation is included.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings